What is it about?
Formulating effective antifungal agents is a constant challenge for researchers, and the same goes for voriconazole. However, a team of scientists has recently created voriconazole-loaded transethosomes (VRCT) using innovative nano-carriers to enhance its solubility and permeation. These optimized VRCT formulations were then incorporated into a carbopol 940 gel, resulting in improved efficacy and patient compliance. Through rigorous evaluation and testing, VRCT and VTEG have demonstrated a 4-fold increase in efficiency against various fungal strains, as well as similar results against L-donovani. With enhanced properties like transdermal flux and reduced inhibitory concentration, this transethosomal formulation can revolutionize drug delivery for topical antifungal treatment
Featured Image
Photo by Bilal O. on Unsplash
Why is it important?
This study is important because it offers an innovative solution for the formulation of antifungal agents. The development of VRCT and VTEG can enhance the efficacy of voriconazole and provide better patient compliance through a topical route.
Perspectives
Writing about the study on VRCT and VTEG was a wonderful experience, not only because of the innovative solution it offers for antifungal drug delivery but also because of the co-authors I collaborated with. Their expertise and insights contributed significantly to the success of the study. Moreover, the study's impact goes beyond the scientific community as it led to rare disease groups reaching out to me. This experience further inspired me to get more involved in rare disease research, and I am grateful for the opportunity to make a difference in people's lives through my work.
Mudassir Farooq
Bahauddin Zakariya University
Read the Original
This page is a summary of: Fabrication and Evaluation of Voriconazole Loaded Transethosomal Gel for Enhanced Antifungal and Antileishmanial Activity, Molecules, May 2022, MDPI AG,
DOI: 10.3390/molecules27103347.
You can read the full text:
Contributors
The following have contributed to this page







